Epigral informs about press release

27 Jan 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed a Press Release for Un-Audited Financial Results - Q3 FY2025. The said Press Release is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.


Epigral Share Price

1318.90 -18.45 (-1.38%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3906.25
Tata Chemicals 765.45
SRF 3097.80
Pidilite Inds. 1447.00
Deepak Nitrite 1739.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×